Prevalence and Measurement of Anxiety in Samples of Patients With Heart Failure: Meta-analysis

Katherine Easton, Peter Coventry, Karina Lovell, Lesley-Anne Carter, Christi Deaton, Katherine Easton, Peter Coventry, Karina Lovell, Lesley-Anne Carter, Christi Deaton

Abstract

Objectives: Rates of anxiety in patients with heart failure (HF) vary widely, and not all assessment instruments used in this patient population are appropriate. It is timely to consolidate the evidence base and establish the prevalence and variance of anxiety in HF samples.

Methods: A systematic review, meta-analysis, and meta-regression were conducted to identify the prevalence, variance, and measurement of anxiety in patients with HF.

Results: A total of 14,367 citations were identified, with 73 studies meeting inclusion criteria. A random effects pooled prevalence of 13.1% (95% confidence interval [CI], 9.25%-16.86%) for anxiety disorders, 28.79% (95% CI, 23.30%-34.29) for probable clinically significant anxiety, and 55.5% (95% CI, 48.08%-62.83%) for elevated symptoms of anxiety was identified. Rates of anxiety were highest when measured using the Brief Symptom Scale-Anxiety scale (72.3%) and lowest when measured using the Generalised Anxiety Disorder-7 (6.3%).

Conclusion: Many patients with HF would benefit if screened for anxiety and treated. The conceptualization and measurement of anxiety accounted for most variance in prevalence rates. The Generalised Anxiety Disorder-7 or the Hospital Anxiety and Depression Scale appear to be the most appropriate instruments for this clinical population, with evidence to suggest they can discriminate between depression and anxiety, omit somatic items that may contaminate identification of anxiety in a population with physical comorbidities, and provide thresholds with which to differentiate patients and target treatments. Although there are limitations with the collation of diverse measurement methods, the current review provides researchers and clinicians with a more granular knowledge of prevalence estimates of anxiety in a population of HF patients.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Flow diagram to show flow of studies in the review and reasons for exclusions.
FIGURE 2.
FIGURE 2.
Prevalence of anxiety disorders, probable clinical anxiety, and elevated symptoms of anxiety in samples of patients with HF grouped by type of anxiety. 0 = specific anxiety disorders group; 1 = probable clinical anxiety group; 2 = elevated symptoms of anxiety above general population norms group. ES indicates effect size; CI, confidence interval.

References

    1. Cimpean D, Drake R. Treating co-morbid medical conditions and anxiety/depression. Epidemiol Psychiatr Sci. 2011;20(2):141–150.
    1. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health: the cost of co-morbidity [report]. The King’s Fund and Centre for Mental Health. 2012.
    1. Vaccarino V, Kasl V. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001;38(1):199–205.
    1. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161(15):1849–1856.
    1. Hallas CN, Wray J, Andreou P, Banner NR. Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung. 2011;40(2):111–121.
    1. Cully JA, Phillips LL, Kunik ME, Stanley MA, Deswal A. Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety. Behav Med. 2010;36(2):70–76.
    1. Rutledge T, Reis SE, Olson MB, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-Sponsored WISE Study. Arch Gen Psychiatry. 1996;63(8):874–880.
    1. Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol. 1996;78(8):890–895.
    1. National Institute for Health and Care Excellence. Clinical Guideline 90. Depression: The Treatment and Management of Depression in Adults. London, England: National Collaborating Centre for Mental Health; 2009.
    1. Konstam V, Moser DK, De Jong MJ. Depression and anxiety in heart failure. J Card Fail. 2005;11(6):455–463.
    1. Merikangas K, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J. Longitudinal trajectories of depression and anxiety in a prospective community sample: The Zurich Cohort Study. Arch Gen Psychiatry. 2003;60:993–1000.
    1. MacMahon KM, Lip GY. Psychological factors in heart failure: a review of the literature. Arch Intern Med. 2002;162(5):509–516.
    1. Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JGF. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail. 2005;7(5):803–808.
    1. Shen BJ, Eisenberg SA, Maeda U, et al. Depression and anxiety predict decline in physical health functioning in patients with heart failure. Ann Behav Med. 2011;41(3):373–382.
    1. Volz A, Schmid JP, Zwahlen M, Kohls S, Saner H, Barth J. Predictors of readmission and health related quality of life in patients with chronic heart failure: a comparison of different psychosocial aspects. J Behav Med. 2011;34(1):13–22.
    1. Haworth JE, Moniz-Cook E, Clark AL, Wang M, Cleland JGF. An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population. Int J Geriatr Psychiatry. 2007;22(11):1147–1153.
    1. Evangelista LS, Ter-Galstanyan A, Moughrabi S, Moser DK. Anxiety and depression in ethnic minorities with chronic heart failure. J Card Fail. 2009;15(7):572–579.
    1. De Jong MJ, Moser DK, Chung ML. Anxiety, depression, and functional status are the best predictors of health status for patients with heart failure. J Card Fail. 2004;10(4):014.
    1. Heo S, Moser DK, Lennie TA, Zambroski CH, Chung ML. A comparison of health-related quality of life between older adults with heart failure and healthy older adults. Heart Lung. 2007;36(1):16–24.
    1. Singleton N, Bumpstead R, O’Brien M, et al. Psychiatric Morbidity Among Adults Living in Private Households, 2000. London, England: The Stationery Office; 2001.
    1. Easton K. An Investigation Into the Nature, Prevalence and Severity of Anxiety in Heart Failure Patients: The Association Between Anxiety and Patient’ Health Outcomes [doctoral thesis]. United Kingdom: The University of Manchester; 2013. . Accessed March 27, 2015.
    1. Zigmond AS, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370.
    1. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–1221.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. 4th ed Washington, DC: American Psychiatric Association; 2004.
    1. Ware J, Sherbourne C. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Med Care. 1992;30(6):473–483.
    1. Gellatly J, Bower P, Hennessy S, Richards D, Gilbody S, Lovell K. What makes self-help interventions effective in the management of depressive symptoms? Meta-analysis and meta-regression. Psychol Med. 2007;37(9):1217–1228.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
    1. Simunovic N. Methodological issues in systematic reviews and meta-analyses of observational studies in orthopaedic research. J Bone Joint Surg Am. 2009. 1;91(suppl 3):87–94.
    1. Deeks J, Dinnes J, D’Amico R, Sowden A, Sakarovitch C. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):186.
    1. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLoS Med. 2007;4:e296.
    1. Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1(2):37–39.
    1. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
    1. Crawford J, Henry J, Crombie C, Taylor EP.Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001;40(4):429–434.
    1. Jiang W, Kuchibhatla M, Cuffe MS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004;110(22):3452–3456.
    1. Clarke SP, Frasure-Smith N, Lesperance F, Bourassa MG. Psychosocial factors as predictors of functional status at 1 year in patients with left ventricular dysfunction. Res Nurs Health. 2000;23(4):290–300.
    1. Sutton A. Systematic reviews of trials and other studies. Health Technol Assess. 1998;2(19):1–276.
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
    1. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP; 2009.
    1. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21(11):1559–1574.
    1. Eisenberg SA, Shen BJ, Schwarz ER, Mallon S. Avoidant coping moderates the association between anxiety and patient-rated physical functioning in heart failure patients. J Behav Med. 2012;35(3):253–261.
    1. Peters-Klimm F, Muller-Tasch T, Schellberg D, et al. Rationale, design and conduct of a randomised controlled trial evaluating a primary care-based complex intervention to improve the quality of life of heart failure patients: HICMan (Heidelberg Integrated Case Management). BMC Cardiovasc Disord. 2007;7:25.
    1. Muller-Tasch T, Frankenstein L, Holzapfel N, et al. Panic disorder in patients with chronic heart failure. J Psychosom Res. 2008;64(3):299–303.
    1. Abrams TE, Vaughan-Sarrazin M, Rosenthal GE. Variations in the associations between psychiatric comorbidity and hospital mortality according to the method of identifying psychiatric diagnoses. J Gen Intern Med. 2008;23(3):317–322.
    1. Kulcu DG, Kurtais Y, Tur BS, Gulec S, Seckin B. The effect of cardiac rehabilitation on quality of life, anxiety and depression in patients with congestive heart failure. A randomized controlled trial, short-term results. Eura Medicophys. 2007;43(4):489–497.
    1. Schweitzer RD, Head K, Dwyer JW. Psychological factors and treatment adherence behavior in patients with chronic heart failure. J Cardiovasc Nurs. 2007;22(1):76–83.
    1. Moser DK, Dracup K, Evangelista LS, et al. Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung. 2010;39(5):378–385.
    1. Serafini G, Pompili M, Innamorati M, Iacorossi G, Cuomo I, Vista MD, et al. The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional study. Prim Care Companion J Clin Psychiatry. 2010;12(6):e1–e9.
    1. Schiffer AA, Pedersen SS, Broers H, Widdershoven JW, Denollet J. Type-D personality but not depression predicts severity of anxiety in heart failure patients at 1-year follow-up. J Affect Disord. 2008;106(1–2):73–81.
    1. Kostis JB, Rosen RC, Cosgrove NM, Shindler DM, Wilson AC. Non-pharmacologic therapy improves functional and emotional status in congestive heart failure. Chest. 1994;106(4):996–1001.
    1. Paukert AL, LeMaire A, Cully JA. Predictors of depressive symptoms in older veterans with heart failure. Aging Ment Health. 2009;13(4):601–610.
    1. Corvera-Tindel T, Doering LV, Roper J, Dracup K. Emotional functioning drives quality of life in men with heart failure. Prog Cardiovasc Nurs. 2009;24(1):2–11.
    1. Dracup K, Westlake C, Erickson VS, Moser DK, Caldwell ML, Hamilton MA. Perceived control reduces emotional stress in patients with heart failure. J Heart Lung Transplant. 2003;22(1):90–93.
    1. Dracup K, Evangelista LS, Hamilton MA, et al. Effects of a home-based exercise program on clinical outcomes in heart failure. Am Heart J. 2007;154(5):877–883.
    1. Moser DK, Doering LV, Chung ML. Vulnerabilities of patients recovering from an exacerbation of chronic heart failure. Am Heart J. 2005;150(5):984.
    1. Doering LV, Dracup K, Caldwell MA, et al. Is coping style linked to emotional states in heart failure patients? J Card Fail. 2004;10(4):344–349.
    1. Sullivan MJ, Wood L, Terry J, et al. The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J. 2009;157(1):84–90.
    1. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press, Inc; 1996.
    1. Spitzer RL, Williams JW, Kroenke K. Utility of a new procedure for diagnosing mental disorders in primary care: The prime-md 1000 study. JAMA. 1994;272(22):1749–1756.
    1. World Health Organization. World Health Organisation (2010) ICD 10: Version 10. 2014.
    1. Bryant C, Jackson H, Ames D. The prevalence of anxiety in older adults: methodological issues and a review of the literature. J Affect Disord. 2008;109(3):233–250.
    1. Januzzi JL, Jr, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med. 2000;160(13): 1913–1921.
    1. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med. 1996;58(5):395–401.
    1. Sear S, Conti J. Quality of life and psychological functioning of ICD patients. Heart. 2002;87(5):488–493.
    1. Yu DS, Thompson DR, Yu CM, Oldridge NB. Assessing HRQL among Chinese patients with coronary heart disease: angina, myocardial infarction and heart failure. Int J Cardiol. 2009;131(3):384–394.
    1. Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J. 2006;152(5):940.
    1. Brown T, O’Leary T, Barlow D. Generalised anxiety disorder. In: Barlow DH. ed. Clinical handbook of psyhcological disorders: a step-by-step treatment manual. 3rd ed New York, NY: Guilford Press; 2001.
    1. Moser DK. “The rust of life”: impact of anxiety on cardiac patients. Am J Crit Care. 2007;16(4):361–369.
    1. Heo S, Moser DK, Widener J. Gender differences in the effects of physical and emotional symptoms on health-related quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2007;6(2):146–152.
    1. Lenze EJ, Mulsant BH, Shear MK, Alexopoulos GS, Frank E, Reynolds CF. Comorbidity of depression and anxiety disorders in later life. Depress Anxiety. 2001;14(2):86–93.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.
    1. Coyne J, Van Sonderen E. The Hospital Anxiety and Depression Scale (HADS) is dead, but like Elvis, there will still be citings. J Psychosom Res. 2012;73(1):77–78.
    1. Ruz A, Lennie T, Reigalel B, McKinley S, Doering L, Moser D. Evidence that the brief symptom inventory can be used to measure anxiety quickly and reliably in patients hospitalized for acute myocardial infarction. J Cardiovasc Nurs. 2010;25(5):117–123.
    1. Derogatis R, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595–605.
    1. Zuckerman M, Lubin B. Manual for the Multiple Affect Adjective Check List-Revised (MAACL-R). San Diego, CA: Educational and Industrial Testing Service; 1985.
    1. National IAPT Programme Team. The IAPT Data Handbook. 2011. . Accessed March 27, 2015.
    1. Dickersin K. Systematic reviews in epidemiology: why are we so far behind? Int J Epidemiol. 2002;31(1):6–12.
    1. Egger M, Davey Smith G, Altman D. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London, England: BMJ; 2001.
    1. Ioannidis J, Patsopoulos N, Rothstein H. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ. 2008;336(1413):1415.
    1. Morton S. Meta-regression approaches: what, why, when and how? Rockville, MD: Agency for Healthcare Research and Quality. Technical Review 8. AHRQ Publication No 04–0033; 2004.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera